Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy Michelle N. MessmerColleen S. NetherbyScott I. Abrams Review 29 November 2014 Pages: 1 - 13
Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment Urban ŠvajgerMartina GobecIrena Mlinarič-Raščan Original Article 25 September 2014 Pages: 15 - 27
Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer Leah J. NovingerTakamaru AshikagaDavid N. Krag Original Article 27 September 2014 Pages: 29 - 39
Evaluation of complement proteins as screening markers for colorectal cancer Line StormIb J. Christensenthe Danish Study Group on Early Detection of Colorectal Cancer Original Article 27 September 2014 Pages: 41 - 50
Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer Hideki KimuraYukiko MatsuiYuichi Sakairi Original Article Open access 28 September 2014 Pages: 51 - 59
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways Balaji BalasaRui YunAudie G. Rice Original Article Open access 07 October 2014 Pages: 61 - 73
Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy Snezana Zivancevic SimonovicOlgica MihaljevicLjiljana Mijatovic Teodorovic Original Article 09 October 2014 Pages: 75 - 82
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies Chiara CastelliLicia RivoltiniPaola Allavena Focussed Research Review 04 July 2014 Pages: 83 - 89
Cancer stem cells: perspectives for therapeutic targeting Cristina MaccalliRuggero De Maria Focussed Research Review 08 August 2014 Pages: 91 - 97
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer Zlatko TrajanoskiCristina MaccalliPaolo Dellabona Focussed Research Review 28 August 2014 Pages: 99 - 104
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy? Luana CalabròGiovanni Luca CeresoliMichele Maio Focussed Research Review 19 September 2014 Pages: 105 - 112
Armed antibodies for cancer treatment: a promising tool in a changing era Riccardo DanielliRoberto PatuzzoMario Santinami Focussed Research Review 15 October 2014 Pages: 113 - 121
Overcoming the toxicity hurdles of genetically targeted T cells Monica CasucciRobert E. HawkinsAttilio Bondanza Focussed Research Review 09 December 2014 Pages: 123 - 130
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 Michele MaioHugues Jean Marie NicolayGiorgio Parmiani Meeting Report 04 July 2014 Pages: 131 - 135